SOURCE: John Thomas Financial
NEW YORK, NY--(Marketwire - Sep 10, 2012) - John Thomas Financial, a full service independent broker/dealer and investment-banking firm located in New York City's Financial District, today announced the formation of a new division, Highline Research Advisors, focused on providing premium investment banking services to companies in the healthcare sector. Highline Research Advisors will provide the full spectrum of investment banking services, including financings, equity research, M&A and advisory services to clients across the range of market capitalizations, from start-ups to Big Pharma companies.
John Thomas Financial, with a robust fleet of retail brokers and the buying power represented by its clients, provides dynamic retail placement distribution that will complement the new Division's institutional placements.
The group's President, Theodore E. Kalem, brings two decades of experience in healthcare investment banking at Bear Stearns, Lehman Brothers and JP Morgan. Managing Director, Dr. Nickolay V. Kukekov, has nearly a decade of experience in the industry. He received his Ph.D. in neuroscience from Columbia University. Dr. Kukekov holds a number of research scholarship awards and peer review publications.
John Thomas Financial CEO Thomas Belesis has spearheaded the firm's continuing growth in recent years via a series of strategic hires and adding niche services. In January the firm announced a robust expansion and enhancement of its investment-banking platform with the hiring of Avi Mirman as the Head of Investment Banking and his highly experienced banking team.
"In a sector as complex as healthcare, institutions look to specialists that can lead them to informed and strategic investment decisions. Mr. Kalem and Dr. Kukekov's extensive experience and deep understanding of the sciences that the sector depends on is rare and valuable. John Thomas Financial is proud to be able to offer clients such comprehensive research and advisory services in the arena of healthcare and pharmaceutical investments," said Mr. Belesis.
"Nickolay and I are very excited about this opportunity to create a premier institutional healthcare investment banking business within John Thomas Financial, and continuing to build upon the world-class platform that Mr. Belesis has established. We look forward to building upon the firm's remarkable success to date," said Mr. Kalem.
For timely insights, news, and commentary on economics and financial markets, visit the JTF Blog or join the John Thomas Financial community on Twitter and Facebook.
About John Thomas Financial
John Thomas Financial, a member of FINRA and SIPC, is an independent broker-dealer and investment banking firm headquartered in New York City's Wall Street district. Emphasizing a client-centric approach to managing all aspects of its business, John Thomas Financial and its affiliates offer a full complement of retail brokerage, private wealth management, and corporate advisory services tailored to the unique needs of its clients. The firm publishes the Fiscal Liquidity Index, a unique daily indicator that looks at government spending and its impact on the financial markets, The Kaufman Report, a weekly technical stock market analysis, and The John Thomas Financial Economic Outlook, a report analyzing consumer sentiment, market outlook, credit cycles and dozens of other market influences.